China Resources Medical Holdings Issues Profit Warning, Expects 20-25% Decline in H1 2025 Profit

Reuters
04 Aug
China Resources Medical Holdings Issues Profit Warning, Expects 20-25% Decline in H1 2025 Profit

China Resources Medical Holdings Company Limited has issued a profit warning, indicating a significant decrease in profits for the first half of 2025. The company expects a decline in profit attributable to the owners by approximately 20% to 25% compared to the same period in 2024. When excluding one-off compensation and supply chain losses from the Yan Hua IOT Agreement, the profit decrease is projected to be around 55% to 60%. This downturn is primarily attributed to a reduction in operating profits from member medical institutions, driven by a decrease in average revenues. Shareholders and potential investors are advised to exercise caution and await further details in the upcoming interim results announcement scheduled before the end of August 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Medical Holdings Co. Ltd. published the original content used to generate this news brief on August 04, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10